Article Information
PubMed
Print ISSN
Online ISSN
History
- Received September 14, 2008
- Accepted November 19, 2008
- Published online January 21, 2009.
Article Versions
- Earlier version (November 20, 2008 - 11:55).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Iris Hecht,
- Jiang Rong,
- André L. F. Sampaio,
- Chen Hermesh,
- Caleb Rutledge,
- Ronen Shemesh,
- Amir Toporik,
- Merav Beiman,
- Liat Dassa,
- Hagit Niv,
- Gady Cojocaru,
- Arie Zauberman,
- Galit Rotman,
- Mauro Perretti,
- Jakob Vinten-Johansen and
- Yossi Cohen
- Compugen Ltd., Tel Aviv, Israel (I.H., C.H., R.S., A.T., M.B., L.D., H.N., G.C., A.Z., G.R., Y.C.); Carlyle Fraser Heart Center of Emory University and Emory Crawford Long Hospital, Atlanta, Georgia (J.R., C.R., J.V.-J.); and William Harvey Research Institute, Barts and the London Medical School, London, United Kingdom (A.L.F.S., M.P.)
- Address correspondence to:
Dr. Iris Hecht, Compugen Ltd., 72 Pinchas Rosen St., Tel Aviv, Israel 69512. E-mail: iris.hecht{at}cgen.com
Statistics from Altmetric.com
Article usage
In this issue
A Novel Peptide Agonist of Formyl-Peptide Receptor-Like 1 (ALX) Displays Anti-Inflammatory and Cardioprotective Effects
